Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-02 · accession 0001384243-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-04 | 2026-02-02+ | KNSA | Quart Barry D | Dir | M - OptEx | $15.47 | +16.0K | 15.1K | New | +$246.9K |
| DM | 2026-02-04 | 2026-02-02+ | KNSA | Quart Barry D | Dir | S - Sale+OE | $45.22 | -16.0K | 12.5K | -56% | -$721.6K |
| DM | 2026-02-04 | 2026-02-02+ | KNSA | Quart Barry D | Dir | M - OptEx | $0.00 | -16.0K | 5,402 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-02-02 | M | A | 830 | $15.47 | 13,376 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2026-02-02 | S | D | 830 | $45.00 | 12,546 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.02. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2026-02-03 | M | A | 12,528 | $15.47 | 25,074 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2026-02-03 | S | D | 12,528 | $45.27 | 12,546 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2026-02-04 | M | A | 2,602 | $15.47 | 15,148 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2026-02-04 | S | D | 2,602 | $45.02 | 12,546 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.05. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Derivative | Share Option | 2026-02-04 | M | D | 2,602 | $0.00 | 2,800 | D | $15.47 · — to 2029-05-28 | 2,602 Class A Ordinary Shares | (F5) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2026-02-02 | M | D | 830 | $0.00 | 17,930 | D | $15.47 · — to 2029-05-28 | 830 Class A Ordinary Shares | (F5) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2026-02-03 | M | D | 12,528 | $0.00 | 5,402 | D | $15.47 · — to 2029-05-28 | 12,528 Class A Ordinary Shares | (F5) The option is fully vested and exercisable. |